Creating Improved Crops and Biofuels
through Biotechnology

 

.: About FGL

FGL is a privately-held company with R&D expertise in several fields of biotechnology including molecular biology, in vitro culture and genetic testing/analyses.  Current areas of interest include commercial development of genetically engineered disease-resistant grapevine varieties, which are now in field tests, and exploratory research with other crops, including citrus. Research projects targeted to increase the efficiency of biofuel production are in development.



.: News & Releases

----------- 2 0 0 7 -----------

- FGL announces license of patented Bidirectional Dual Promoter Complex for enhanced gene expression in plants, animals and fungi.

- Grape biotechnology research update available as PowerPoint presentation. (download 5 Mb file).

- Genetically-modified grapevines planted into field test sites in U.S. Virgin Islands (1/07) and Florida (4/07) are being evaluated for resistance to Pierce's disease and a range of fungal diseases.

---------- 2 0 0 6 -----------

- FGL incorporated in 2006.

- USDA APHIS approves field test sites for genetically-modified grape in the US Virgin Islands and Florida 11/06.


- FGL executes agreement with the University of Florida 12/06 licensing US and International biotechnology-related patents protecting grape genetic improvement and widely-applicable molecular biology techniques for plant/microbe engineering and biofuel development.  

Copyright: Florida Genetics LLC - 2007